Interaction Guide · Research summary

Can I take Red Yeast Rice with Ketoconazole?

Review Red Yeast Rice with Ketoconazole: possible adverse effects, preparation details, evidence limits, and sources.

Prepared by Dr. Edward M.Kim, PharmD · Clinical Director, SupplementSafety editorial team

Research summary published · Prepared · Editorial update

The short answer

Avoid starting red yeast rice with oral ketoconazole without the prescriber’s review. Some products contain monacolin K, the same compound as lovastatin, which is contraindicated with oral ketoconazole because of muscle-toxicity risk.

What this answer covers

Monacolin-containing red yeast rice with oral ketoconazole. Monacolin K identity with lovastatin is explicit; content varies and not all products contain detectable amounts.

Supplement or preparation
Red yeast rice
Medication ingredient
ketoconazole

Check the exact medicine and regimen

This review applies to oral ketoconazole tablets, whose use is limited because of serious systemic risks. It does not assign the same interactions to ketoconazole shampoo or skin cream. Keep the prescribed indication, other medicines and liver-monitoring plan in view.

The active constituent matters

Red yeast rice can contain monacolin K, chemically identical to lovastatin. The ketoconazole label contraindicates lovastatin because inhibiting its metabolism can increase exposure and muscle toxicity. This is a defined-constituent bridge, not a measured trial of every red yeast rice product.

Product weight does not establish the dose

An analytical study found large differences in monacolin K among 28 brands, including two without detectable amounts. A label showing only milligrams of fermented rice cannot reliably identify the active dose. Those findings do not demonstrate that an untested product is safe.

A time gap is not a substitute

Discuss the cholesterol-treatment plan and exact product with the prescriber. A few hours of separation has not been shown to prevent this metabolic interaction. New muscle pain or marked weakness warrants prompt assessment; continue the prescribed monitoring for oral ketoconazole’s separate liver risks.

Evidence and practical considerations

Side effects & toxicity

A constituent-based muscle-toxicity precaution is supported for monacolin-containing products; a universal combined liver/muscle toxicity rate is not established.

Exact scope
Monacolin-containing red yeast rice with oral ketoconazole. Monacolin K identity with lovastatin is explicit; content varies and not all products contain detectable amounts. with RxNorm 6135 IN ketoconazole. Exact oral 200 mg base tablets; topical creams, shampoos and other local routes are not comparable systemic exposure.
Medication form and route
Oral

What remains uncertain

  • Analytical constituent identity plus lovastatin contraindication, not an exact red-yeast-rice combination trial. Original bundled liver/muscle/elevated-level claim exceeds measured exact-pair evidence; no universal product event rate.

Factors that may matter: Exact oral regimen and formulation; Booster or fixed-combination context; Mineral preparation and dosing order; Food requirements.

Research conclusion: supported with conditions · Evidence assessment: moderate

Read the supporting source summaries

Source 1: Current original prescribing information

dailymed.nlm.nih.gov · Source check Sep 10, 2026

Population: Patients prescribed the specified oral regimen.

Reduced acidity impairs absorption; acid-neutralizing drugs at least one hour before or two hours after. Serious liver toxicity warning and contraindication with lovastatin/simvastatin.

How this applies: RxNorm 6135 IN ketoconazole. Exact oral 200 mg base tablets; topical creams, shampoos and other local routes are not comparable systemic exposure.

No automatic topical route transfer, fruit-extract interaction or every-mineral binding effect. Constituent bridges and liver-risk precaution distinct from exact-pair clinical event data.

Source 2: Original clinical research

pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026

Population: 28 commercial red yeast rice brands.

Monacolin K, chemically identical to lovastatin, varied markedly; absent in two brands.

How this applies: Exact reported regimen, preparation and endpoints only; other drugs or forms remain indirect.

Analytical study, not a ketoconazole co-use trial. Product mass does not establish monacolin dose.

Source 3: Medication terminology

rxnav.nlm.nih.gov · Source check Sep 10, 2026

Population: Terminology.

ketoconazole is IN.

How this applies: Exact ingredient.

Not clinical evidence.

Research assessment: · Open full citations ↗

Review and change history

Publication status
Published research summary
Clinical review
Not yet recorded
DateUpdate
Research summary published
Article prepared
Sources checked and article drafted.

Article revision: 64f0b7971a7044e7

This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.

Full citations require verification. Reading this answer and the source summaries does not.

Taking other supplements or medications?

Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.

Open the interaction checker

Information, not medical advice. Do not change prescribed treatment based on this guide.